Keyword Analysis & Research: kite pharma
Keyword Research: People who searched kite pharma also searched
Search Results related to kite pharma on Search Engine
-
Kite Pharma, Changing the Way Cancer is Treated
https://www.kitepharma.com/
WebKite is dedicated to curing cancer. Learn about the science of cell therapy, our cancer research, and our cancer treatments in the pipeline.
DA: 27 PA: 4 MOZ Rank: 5
-
Careers at Kite Pharma
https://www.kitepharma.com/careers/careers-at-kite
WebTO US. Everyone at Kite is grounded by one common goal – curing cancer. Our personalized approach is what sets us apart from other health and life science companies. Unlike traditional pharmaceutical manufacturing, our therapies are not …
DA: 69 PA: 89 MOZ Rank: 68
-
Kite Pharma - Wikipedia
https://en.wikipedia.org/wiki/Kite_Pharma
WebKite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells.
DA: 59 PA: 93 MOZ Rank: 93
-
Transformational Cancer Treatment | Kite Pharma
https://www.kitepharma.com/about-us/our-mission
WebTransformational Cancer Treatment. At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. We believe cell therapy has the ability to change the way cancer is treated. Our industry-leading cell therapy technology ...
DA: 28 PA: 22 MOZ Rank: 82
-
Announcement: Kite Pharma Acquisition | Gilead
https://www.gilead.com/news-and-press/company-statements/kite-pharma
WebGilead Completes Acquisition of Kite Pharma. Gilead Sciences has completed the acquisition of Kite Pharma and is proud to officially welcome Kite’s more than 700 talented employees to the Gilead organization – for further details on the acquisition, click here.
DA: 79 PA: 70 MOZ Rank: 53
-
U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T …
https://www.gilead.com/news-and-press/press-room/press-releases/2021/10/us-fda-approves-kites-tecartus-as-the-first-and-only-car-t-for-adults-with-relapsed-or-refractory-bcell-acute-lymphoblastic-leukemia
WebOctober 01, 2021. U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia. -- 65% of Patients Achieved Overall Complete Remission with Tecartus -- -- High Unmet Need: Fifty Percent of Adult Patients Will Relapse on Currently Available Treatments --
DA: 78 PA: 8 MOZ Rank: 2
-
Kite’s Car T-cell Therapy Yescarta® Demonstrates High …
https://www.gilead.com/news-and-press/press-room/press-releases/2023/9/kites-car-t-cell-therapy-yescarta-demonstrates-high-response-rate-and-durable-remission-in-alycante-study-as-initial-treatment-for-transplant-inelig
WebSep 18, 2023 · SANTA MONICA, Calif.-- (BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced results from the Phase 2 ALYCANTE study, led and sponsored by the French collaborative group LYSA/LYSARC, for use of its chimeric antigen receptor (CAR) T-cell therapy Yescarta ® (axicabtagene ciloleucel) in patients with …
DA: 88 PA: 22 MOZ Rank: 47
-
Kite Receives U.S. FDA Approval of Manufacturing Process …
https://finance.yahoo.com/news/kite-receives-u-fda-approval-133000210.html
WebJan 30, 2024 · SANTA MONICA, Calif., January 30, 2024 -- ( BUSINESS WIRE )--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing...
DA: 42 PA: 88 MOZ Rank: 95
-
Our Focus on Cell Therapy | Kite Pharma
https://www.kitepharma.com/about-us/our-story
WebOur Story. A Singular Focus on Cell Therapy. Founded in 2009 as a pioneer in cell therapy research, Kite’s leadership position in the immuno-oncology space was solidified with our research and development agreement with the National Cancer Institute in 2012 and when our commercial manufacturing site opened in El Segundo in 2016.
DA: 83 PA: 34 MOZ Rank: 54
-
Kite Pharma | LinkedIn
https://www.linkedin.com/company/kite-pharma-inc-
WebAbout us. At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as...
DA: 31 PA: 45 MOZ Rank: 11
